Company intelligence / Profile preview
Beren Therapeutics
Thousand Oaks, California, United Statesberenla.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Beren Therapeutics is a private, vertically integrated biopharmaceutical public benefit corporation developing cyclodextrin-based small‑molecule therapeutics to treat diseases driven by pathogenic lipid/compound accumulation; lead program BRN‑002 for homozygous familial hypercholesterolemia has completed Phase 1 trials in healthy volunteers with ongoing development, and additional cyclodextrin programs, including adrabetadex for Niemann‑Pick disease type C via subsidiary Mandos, are in development.
- Therapeutic areas
- CardiovascularRare Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Roquette (strategic investment and innovation agreement to expand cyclodextrin technologies and medicinal applications)UTokyo Innovation Platform (UTokyo IPC) / AOI 1 Fund investment and collaboration to expand discovery operations in JapanJIC Venture Growth Investments (portfolio investor in Beren Therapeutics P.B.C.)
Beyond the preview
Go deeper on Beren Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beren Therapeutics.